For Eg5-driven sliding, the inhibitory effects of added ADP are dramatically enhanced by adding monastrol (Figure 1B) . This synergy is consistent with an allosteric mechanism in which monastrol increases the affinity of Eg5 for ADP, thereby stabilising a pre-existing, on-pathway, Eg5-ADP conformation. We supported this interpretation using proteolytic fingerprinting to demonstrate a monastroldependent increase in the ADP binding affinity of Eg5 (Supplemental Data).
sliding assays, but does not cause the microtubules to dissociate from the Eg5 surface [1] . On the other hand, kinetic data indicate that monastrol stabilises an ADP state of Eg5, and Eg5-ADP is reported to be a weak binding state with a low affinity for microtubules [7] .
To find out whether the ternary Eg5-monastrol-ADP complex is binding weakly or strongly to microtubules, we ran 'tug-o'-war' motility assays in which microtubules move on mixed surfaces of kinesin (rat brain kinesin 1, kif5b) and Eg5 (Xenopus Eg 5.2). Monastrol inhibits only the Eg5 component on these mixed surfaces, allowing us to ask whether the rat kinesin can overcome the frictional resistance due to monastrol-inhibited Eg5. Figure 1 For Eg5-driven sliding, the inhibitory effects of added ADP are dramatically enhanced by adding monastrol ( Figure 1B ). This synergy is consistent with an allosteric mechanism in which monastrol increases the affinity of Eg5 for ADP, thereby stabilising a pre-existing, on-pathway, Eg5-ADP conformation. We supported this interpretation using proteolytic fingerprinting to demonstrate a monastroldependent increase in the ADP binding affinity of Eg5 (Supplemental Data).
Supposing that the low-friction Eg5-ADP "monastrol state" is indeed on-pathway for the normal kinetic cycle of Eg5, how would it fit into the kinetic scheme, and what might be its function? Figure  1C Current Biology
